泛发性脓疱型银屑病发作的真实世界临床特征与治疗模式
患者年均发作率为0.91次/人/年(中位数0.51),发作间期平均5.9个月(中位数3.8个月),围发作期处方量先升后降,超说明书生物制剂和非甾体系统药物频繁调整。
要点
- 63%的GPP患者经历至少1次发作,年均发作率约0.91次/人/年
- 发作间期平均5.9个月,中位数3.8个月
- 围发作期处方量先升后降,超说明书治疗频繁调整,提示长期疗效需求未满足
核心结论
- GPP患者在接受传统超说明书治疗下仍频繁发作,治疗过程频繁调整,提示对有效长期治疗方案存在未满足需求。
研究设计与样本
- 队列研究,利用OMNY Health真实世界数据平台2017-2023年皮肤科门诊电子健康记录,共638例GPP患者,以首次GPP诊断代码索引,采用既往开发的算法判定就诊层面的发作状态。
主要发现
- 发作患者更可能为女性、年轻、非白人、西班牙裔/拉丁裔、有感染/寄生虫病史且GPP更活动。
- 年均发作率均值0.91次/人/年(中位数0.51),发作间期均值5.9个月(中位数3.8个月)。
- 从发作前到发作期处方增加,发作后减少;观察到超说明书生物制剂和非甾体系统药物频繁调整。
临床怎么用
- 临床应关注GPP患者发作频率及治疗调整情况,评估传统超说明书治疗的长期有效性。
- 对女性、年轻、非白人、西班牙裔/拉丁裔及有感染病史的GPP患者,需警惕更高发作风险。
局限性
- 数据来自美国门诊皮肤科实践,GPP发作的记录可能不全面或不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical characteristics and treatment of generalized pustular psoriasis (GPP) flares are poorly understood. OBJECTIVE: To characterize patients by GPP flare status, quantify flare timing/frequency, and understand peri-flare treatment patterns. METHODS: This cohort study utilized electronic health records (2017-2023) from outpatient dermatology clinics in the OMNY Health real-world data platform. Patients were indexed at first GPP diagnosis code; encounter-level GPP flare status was established from previously developed algorithms. Annualized flare rate, time between flares, and peri-flare treatment patterns were described. RESULTS: Four hundred four of 638 patients (63%) experienced ≥1 flare episode. Patients who experienced a flare were more likely to be female, younger, nonwhite, Hispanic/Latino, have infectious/parasitic disease history, and more active GPP. Mean (median) annualized flare rate was 0.91 (0.51) flares/patient/year; mean (median) time between flares was 5.9 (3.8) months. Prescriptions increased from preflare period to flare episode, then decreased during the postflare period. Frequent treatment alterations of off-label biologics and nonsteroidal systemic agents were observed. LIMITATIONS: Data were from US-based outpatient dermatology practices; documentation of GPP flares may not have been comprehensive or consistent in this setting. CONCLUSION: GPP patients continue to experience frequent flares with traditional off-label therapies. Patients' course of treatment was altered frequently, suggesting an unmet need for effective long-term GPP therapies.
引用
- Rhoads JLW, Lavasani L, Rasouliyan L, et al. Real-world clinical characteristics and treatment patterns of generalized pustular psoriasis flares. J Am Acad Dermatol. 2025. PMID: 39933611. doi:10.1016/j.jaad.2025.02.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。